Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Current Assets: 2014-2024

Historic Current Assets for Viking Therapeutics (VKTX) over the last 11 years, with Dec 2024 value amounting to $907.2 million.

  • Viking Therapeutics' Current Assets fell 21.13% to $738.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $738.7 million, marking a year-over-year decrease of 21.13%. This contributed to the annual value of $907.2 million for FY2024, which is 147.05% up from last year.
  • Viking Therapeutics' Current Assets amounted to $907.2 million in FY2024, which was up 147.05% from $367.2 million recorded in FY2023.
  • Viking Therapeutics' 5-year Current Assets high stood at $907.2 million for FY2024, and its period low was $167.0 million during FY2022.
  • Over the past 3 years, Viking Therapeutics' median Current Assets value was $367.2 million (recorded in 2023), while the average stood at $480.5 million.
  • As far as peak fluctuations go, Viking Therapeutics' Current Assets fell by 20.66% in 2022, and later surged by 147.05% in 2024.
  • Viking Therapeutics' Current Assets (Yearly) stood at $256.1 million in 2020, then declined by 17.80% to $210.5 million in 2021, then declined by 20.66% to $167.0 million in 2022, then skyrocketed by 119.84% to $367.2 million in 2023, then soared by 147.05% to $907.2 million in 2024.